Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022

Vaccines against smallpox are known to have cross-protective activity against monkeypox, and smallpox and monkeypox infections are believed to generate permanent immunity. Nevertheless, there are scarce data about the possibility of reinfection or reactivation. Recently, a case of apparent monkeypox reinfection has been reported. We present a suspected case of second episode of monkeypox in a healthy and previously vaccinated man, with a confirmed primary monkeypox infection occurring three months before the second confirmed presentation.

[1]  M. Tay,et al.  Monkeypox: disease epidemiology, host immunity and clinical interventions , 2022, Nature Reviews Immunology.

[2]  M. Aepfelbacher,et al.  Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus. , 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  P. Ortiz-Romero,et al.  Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study , 2022, The Lancet.

[4]  A. Antinori,et al.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.

[5]  Jennifer L. Small,et al.  Clinical features and management of human monkeypox: a retrospective observational study in the UK , 2022, The Lancet. Infectious diseases.

[6]  Carole R Baskin,et al.  Vaccinia virus vaccines: past, present and future. , 2009, Antiviral research.

[7]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[8]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[9]  A. Rothman,et al.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. , 2002, The Journal of infectious diseases.

[10]  P E Fine,et al.  The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.

[11]  Z. Ježek,et al.  Human monkeypox: clinical features of 282 patients. , 1987, The Journal of infectious diseases.